PUS1
Basic information
Region (hg38): 12:131929200-131945896
Links
Phenotypes
GenCC
Source:
- myopathy, lactic acidosis, and sideroblastic anemia 1 (Definitive), mode of inheritance: AR
- myopathy, lactic acidosis, and sideroblastic anemia 1 (Moderate), mode of inheritance: AR
- myopathy, lactic acidosis, and sideroblastic anemia (Supportive), mode of inheritance: AR
- myopathy, lactic acidosis, and sideroblastic anemia 1 (Strong), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Myopathy, lactic acidosis, and sideroblastic anemia 1 | AR | Hematologic | Severe, non-B6 responsive anemia has reportedly required transfusions | Endocrine; Hematologic; Musculoskeletal; Neurologic | 7726239; 14981724; 15108122; 15103716; 17056637; 19731322; 25227147 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (527 variants)
- Myopathy,_lactic_acidosis,_and_sideroblastic_anemia_1 (84 variants)
- Inborn_genetic_diseases (61 variants)
- Myopathy,_lactic_acidosis,_and_sideroblastic_anemia (52 variants)
- not_specified (31 variants)
- PUS1-related_disorder (21 variants)
- Sideroblastic_anemia (8 variants)
- Inborn_mitochondrial_myopathy (8 variants)
- Mitochondrial_disease (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PUS1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000025215.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 284 | 285 | ||||
| missense | 149 | 15 | 169 | |||
| nonsense | 11 | 18 | ||||
| start loss | 3 | 3 | ||||
| frameshift | 18 | 16 | 34 | |||
| splice donor/acceptor (+/-2bp) | 10 | 10 | ||||
| Total | 29 | 41 | 149 | 299 | 1 |
Highest pathogenic variant AF is 0.000055407727
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PUS1 | protein_coding | protein_coding | ENST00000376649 | 6 | 14662 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00167 | 0.974 | 125729 | 0 | 12 | 125741 | 0.0000477 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.291 | 250 | 263 | 0.949 | 0.0000171 | 2758 |
| Missense in Polyphen | 85 | 106.14 | 0.80084 | 1133 | ||
| Synonymous | -0.154 | 123 | 121 | 1.02 | 0.00000867 | 861 |
| Loss of Function | 1.98 | 7 | 15.4 | 0.455 | 6.57e-7 | 193 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000615 | 0.0000615 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.000139 | 0.000139 |
| European (Non-Finnish) | 0.0000447 | 0.0000440 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000653 | 0.0000653 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Converts specific uridines to PSI in a number of tRNA substrates. Acts on positions 27/28 in the anticodon stem and also positions 34 and 36 in the anticodon of an intron containing tRNA. Involved in regulation of nuclear receptor activity through pseudouridylation of SRA1 RNA. {ECO:0000269|PubMed:24722331}.;
- Pathway
- tRNA modification in the nucleus and cytosol;tRNA processing;tRNA modification in the mitochondrion;Metabolism of RNA;Pyrimidine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- loftool
- 0.684
- rvis_EVS
- -0.75
- rvis_percentile_EVS
- 13.58
Haploinsufficiency Scores
- pHI
- 0.487
- hipred
- Y
- hipred_score
- 0.565
- ghis
- 0.599
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.940
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pus1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- tRNA pseudouridine synthesis;mitochondrial tRNA pseudouridine synthesis;mRNA pseudouridine synthesis
- Cellular component
- nucleus;mitochondrion;mitochondrial matrix
- Molecular function
- tRNA binding;steroid receptor RNA activator RNA binding;RNA binding;pseudouridine synthase activity;tRNA pseudouridine synthase activity